School of Medicine, The University of North Carolina at Chapel Hill.
Department of Dermatology, The University of North Carolina at Chapel Hill.
JAMA Dermatol. 2022 Feb 1;158(2):132-141. doi: 10.1001/jamadermatol.2021.4741.
Surgical intervention is frequently needed to treat hidradenitis suppurativa (HS). Patient satisfaction is high based on previous studies, but reports of patient impressions of clinic-based operative experiences and postoperative recovery are limited.
To characterize patient impressions, outcomes, and recovery time after clinic-based surgical treatment of HS and examine patient characteristics associated with outcomes.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included patients 12 years or older who underwent clinic-based surgical procedures for treatment of HS at a single subspecialty HS clinic at the University of North Carolina Department of Dermatology from April 2014 to December 2018. Data analysis was performed from January to September 2021.
Clinic-based deroofing and excisional procedures performed as part of routine care.
The primary outcomes were patient-reported recurrence of HS at the site of surgery, patient satisfaction with the procedures and outcomes, and patient-reported pain and recovery associated with surgery obtained from electronic medical record review and patient questionnaires.
Outcomes of 194 procedures for 78 patients (65 [83%] female; mean [SD] age, 35.1 [12.1] years) were analyzed. Self-reported rate of recurrence was 41% (79 procedures). Despite recurrence, most patients (148 procedures [76%]) were very satisfied with their surgical results. The median number of missed days of work or school was 2 (IQR, 1-7 days), and the median number of days until return to normal activity was 10 (IQR, 3-14 days). In addition, for 126 of the 194 procedures (65%), patients stated that pain during an HS flare was worse than pain during surgical recovery.
In this cohort study, patients reported high rates of satisfaction with clinic-based HS surgery. Recovery was typically rapid, with most patients rating postsurgical pain as less severe than their HS pain.
手术干预常用于治疗化脓性汗腺炎（HS）。根据之前的研究，患者满意度很高，但关于患者对诊所手术经验和术后恢复的印象的报告有限。
描述患者对诊所 HS 手术治疗的印象、结果和恢复时间，并检查与结果相关的患者特征。
设计、地点和参与者：这项回顾性队列研究包括 2014 年 4 月至 2018 年 12 月在北卡罗来纳大学皮肤科 HS 专科诊所接受诊所手术治疗的 12 岁及以上患者。数据分析于 2021 年 1 月至 9 月进行。
作为常规护理一部分进行的诊所去顶和切除术。
主要结果是患者报告手术部位 HS 复发、患者对手术程序和结果的满意度、以及从电子病历回顾和患者问卷调查中获得的与手术相关的疼痛和恢复情况。
对 78 名患者的 194 例手术的结果进行了分析（65 名[83%]女性；平均[SD]年龄，35.1[12.1]岁）。自我报告的复发率为 41%（79 例手术）。尽管有复发，大多数患者（148 例手术[76%]）对手术结果非常满意。错过工作或上学的天数中位数为 2 天（IQR，1-7 天），恢复正常活动的天数中位数为 10 天（IQR，3-14 天）。此外，在 194 例手术中的 126 例（65%）中，患者表示 HS 发作期间的疼痛比手术恢复期的疼痛更严重。
在这项队列研究中，患者报告对诊所 HS 手术的满意度很高。恢复通常很快，大多数患者认为术后疼痛比 HS 疼痛轻。
